Frontlight ResearchEarly access
CompletedNo phase
Association Between Hypomagnesemia and Coagulopathy in Sepsis
Key facts
- Who runs it
- Ain Shams University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 150 people enrolled
- Started
- 1 Apr 2025
- Ended
- 1 Apr 2025
- Type of study
- Observational, 3 groups
- Treatments tested
- Serum magnesium concentration
- Record updated
- 8 May 2026
Who can take part
- Age
- 20 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age ≥ 20 years at the time of Intensive Care Unit (ICU) admission
- Diagnosis of sepsis based on Sepsis-3 criteria [confirmed or suspected infection + Sequential Organ Failure Assessment (SOFA) score ≥ 2]
- Admission to the ICU during the study period
- Serum magnesium level measured at ICU admission
- Coagulation parameters [e.g., platelet count, Prothrombin Time/International Normalized Ratio (PT-INR), fibrinogen, D-dimer] within 24 hours of ICU admission
- Complete clinical and laboratory data for calculating the International Society on Thrombosis and Haemostasis (ISTH) overt Disseminated Intravascular Coagulation (DIC) score
Who cannot take part
- ICU admissions due to non-infectious causes (e.g., trauma, elective surgery without infection)
- Presence of pre-existing coagulopathy or hematologic malignancy affecting baseline coagulation (e.g., leukemia, hemophilia)
- Patients with missing data on serum magnesium or coagulation markers at ICU admission
- Known history of magnesium supplementation prior to ICU admission
- End-stage renal disease on dialysis, which may significantly alter magnesium handling
- Pregnant women, due to altered magnesium physiology
- Patients transferred from or to another hospital within 24 hours of ICU admission (incomplete follow-up)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aimed to investigate the association between hypomagnesemia and coagulopathy in patients with sepsis, with a focus on evaluating whether low serum magnesium levels are independently linked to the development of disseminated intravascular coagulation during intensive care unit admission.
The 3 groups in the trial
- Group I
Patients with hypomagnesemia.
Treatment: Serum magnesium concentration
- Group II
Individuals with normal serum magnesium levels
Treatment: Serum magnesium concentration
- Group III
Patients with hypermagnesemia.
Treatment: Serum magnesium concentration
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of the Association Between Hypomagnesemia and Coagulopathy in Sepsis
- Record updated
- 8 May 2026